Granted Patent
B2
US 8,871,771 · App. 13/861,804 · Granted Oct 28, 2014
Salts of prodrugs of piperazine and substituted piperidine antiviral agents
Inventors:
Yasutsugu Ueda (Clinton, CT); Timothy P. Connolly (Portland, CT); John F. Kadow (Wallingford, CT); Nicholas A. Meanwell (East Hampton, CT); Tao Wang (Farmington, CT); Chung-Pin H. Chen (Madison, CT); Kap-Sun Yeung (Madison, CT); Zhongxing Zhang (Madison, CT); David Kenneth Leahy (Hightstown, NJ); Shawn K. Pack (Lawrenceville, NJ); Nachimuthu Soundararajan (Kendall Park, NJ); Pierre Sirard (St. Jean sur Richelieu, CA); Kathia Levesque (St. Jean sur Richelieu, CA); Dominique Thoraval (Ville St. Laurent, CA)
Assignee:
Bristol-Myers Squibb Company
View Patent ↗
Loading inventors, assignments & file history…
Abstract
This invention provides for prodrug Compounds I, pharmaceutical compositions thereof, and their use in treating HIV infection. wherein: X is C or N with the proviso that when X is N, R 1 does not exist; W is C or N with the proviso that when W is N, R 2 does not exist; V is C; E is hydrogen or a pharmaceutically acceptable salt thereof; and Y is selected from the group consisting of Also, this invention provides for intermediate Compounds II useful in making prodrug Compounds I. wherein: L and M are independently selected from the group consisting of C 1 -C 6 alkyl, phenyl, benzyl, trialkylsilyl, -2,2,2-trichloroethoxy and 2-trimethylsilylethoxy.
Claims (1)
1. The compound, IIc, having the following structure:
Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA PREVIOUSLY RECORDED AT REEL: 039323 FRAME: 0811. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.
Recorded Sep 8, 2016
From: BRISTOL-MYERS SQUIBB COMPANY
To: VIIV HEALTHCARE UK (NO. 4) LIMITED
Reel/Frame 039944/0582 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 13, 2016
From: BRISTOL-MYERS SQUIBB COMPANY
To: VIIV HEALTHCARE (NO. 4) LIMITED
Reel/Frame 039323/0811 →
Continuity (6)
Provisional Application
60635231
· Dec 10, 2004
Provisional Application
60553320
· Mar 15, 2004